{"symbol":"PFE","provider":"yahoo-finance","fetchedAt":"2025-12-23T08:21:31.177Z","asOfDate":"2025-12-23","articles":[{"id":"dec7eb7b-a0ab-3828-8cec-c8c66bd7dc36","title":"UPS and 11 Other Stocks With Sky-High Dividends and No Clear Answers","url":"https://finance.yahoo.com/m/dec7eb7b-a0ab-3828-8cec-c8c66bd7dc36/ups-and-11-other-stocks-with.html","publisher":"Barrons.com","publishedAt":"2025-12-23T07:30:00.000Z","relatedTickers":["CPB","F","UPS","VZ","^GSPC"],"mainIdea":"UPS and 11 Other Stocks With Sky-High Dividends and No Clear Answers","summary":"Barrons.com: UPS and 11 Other Stocks With Sky-High Dividends and No Clear Answers. United Parcel Service has had a devil of a year. While UPS’s dividend yield, one of the highest in the looks tantalizing, Wolfe Research strategist Chris Senyek points out that being in the highest-yielding club doesn’t typically add up to stock market success. Related tickers mentioned: CPB, F, UPS, VZ, ^GSPC."},{"id":"4c8488a3-403f-3c55-9b54-702e7df9bb01","title":"Pill Version of Wegovy Is Approved for Use in the U.S.","url":"https://finance.yahoo.com/m/4c8488a3-403f-3c55-9b54-702e7df9bb01/pill-version-of-wegovy-is.html","publisher":"The Wall Street Journal","publishedAt":"2025-12-22T23:38:00.000Z","relatedTickers":[],"mainIdea":"Pill Version of Wegovy Is Approved for Use in the U.S.","summary":"The Wall Street Journal: Pill Version of Wegovy Is Approved for Use in the U.S.. Novo Nordisk said it plans to start selling the new pill in the U.S. soon after the new year, with a cash price of $149 a month for the starting dose."},{"id":"2dc54035-691e-35fa-af3d-c59a4fb8694a","title":"Bet on These Top-Ranked Healthcare ETFs Before 2025 Ends","url":"https://finance.yahoo.com/news/bet-top-ranked-healthcare-etfs-184300571.html","publisher":"Zacks","publishedAt":"2025-12-22T18:43:00.000Z","relatedTickers":["ABBV","BMY","IHE","JNJ","LLY","VHCIX","VHT","XLV","^GSPC"],"mainIdea":"Bet on These Top-Ranked Healthcare ETFs Before 2025 Ends","summary":"Zacks: Bet on These Top-Ranked Healthcare ETFs Before 2025 Ends. XLV and similar healthcare ETFs are gaining momentum as strength in biotech, increased AI adoption, and rising defensive demand position the sector for year-end leadership. Related tickers mentioned: ABBV, BMY, IHE, JNJ, LLY, VHCIX, VHT, XLV, ^GSPC."}]}
